Chemidex Pharmaceutical Private Limited
Founded in 2015 and headquartered in Delhi, India.
2015 | Delhi (India) | Active
Chemidex Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth 257.59%
- Profit Growth 112.30%
- Ebitda 143.31%
- Net Worth 0.35%
- Total Assets -9.24%
About Chemidex Pharmaceutical
Chemidex Pharmaceutical Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 August 2015 (Nine years and six months 10 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohd Malik, Nupoor Gupta, Mohd Rashid, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2015PTC284290
- Company No.
284290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2015
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Chemidex Pharmaceutical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nupoor Gupta  | Director | 01-Feb-2016 | Current |
| Mohd Malik | Director | 01-Feb-2016 | Current |
| Mohd Rashid | Director | 20-Aug-2015 | Current |
| Mohd Malik | Director | 20-Aug-2015 | Current |
Financial Performance of Chemidex Pharmaceutical.
Chemidex Pharmaceutical Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 257.59% increase. The company also saw a substantial improvement in profitability, with a 112.3% increase in profit. The company's net worth moved up by a moderate rise of 0.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemidex Pharmaceutical?
In 2017, Chemidex Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemidex Pharmaceutical?
Unlock and access historical data on people associated with Chemidex Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemidex Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemidex Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.